Lourdes Santiago, MD
Colon & Rectal Surgery · Clearwater, FLNPI 1063630259
Payments from drug & device makers
Across 862 payments — averaging $36.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch Health US, LLC$24K
- Davol Inc.$3K
- Intuitive Surgical$2K
- Axonics, Inc.$1K
- Olympus America Inc.$739
- TELA Bio, Inc.$133
- plus $330 from 11 others
What the payments were for
- Speaking & faculty fees$2,25029%
- Travel & lodging$2,37230%
- Food & beverage$1,51319%
- Education$1,00013%
- Other$7399%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch Health US, LLC | 796 | $23,938 |
| Davol Inc. | 6 | $3,145 |
| Intuitive Surgical | 10 | $2,221 |
| Axonics, Inc. | 28 | $1,306 |
| Olympus America Inc. | 1 | $739 |
| TELA Bio, Inc. | 1 | $133 |
| Boston Scientific | 4 | $67 |
| Medtronic(2 entities) | 4 | $58 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $33 |
| Molnlycke Health Care US, LLC | 2 | $32 |
| Shire North American Group Inc | 2 | $28 |
| Integra Lifesciences Corporation | 1 | $26 |
| Mimedx Group, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Innovation Technologies Inc | 1 | $19 |
| Dentsply IH AB | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,811 in reported general payments places this provider in the 75th percentile of 157 colon & rectal surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 82 | $13,034 |
| CholestyramineCholestyramine (With Sugar) | 27 | $1,542 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 36 | $702 |
| Metronidazole | 31 | $440 |
| Cephalexin | 21 | $330 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $330 |
| Ciprofloxacin Hcl | 33 | $193 |
| Tramadol Hcl | 42 | $146 |
| Fluconazole | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Clearwater
- Mark SolimanAltamonte Springs$887K
- Avraham BelizonBoca Raton$642K
- Jorge MarcetTampa$627K
- Eduardo Parra DavilaWest Palm Beach$598K
- Matthew AlbertAltamonte Springs$573K
- Jaime SanchezTampa$532K
- Allen ChudzinskiTampa$386K
- Rahila EssaniCelebration$379K
- Henry LujanMiami$378K
- Giovanna da Silva SouthwickWeston$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.